A New Treatment Option for Uncommon EGFR Mutations (BMIC-023) - 102204

Spotlight
Video

A New Treatment Option for Uncommon EGFR Mutations (BMIC-023)

BeaconMedIC has 71 videos Subscribe Here

Loading........
Description: Dr. Jack West reviews the new FDA approval for afatinib (Gilotrif) for specific uncommon EGFR mutations, including G719X, L861Q, and S768I, in advanced NSCLC.
Shared By : BeaconMedIC
Posted on : 01/23/18
Added : 11 months ago